Cargando…

RCC Immune Microenvironment Subsequent to Targeted Therapy: A Friend or a Foe?

Renal cell carcinoma (RCC) is composed of different subtypes with distinct molecular and histological tumor heterogeneity. Although the advent of various targeted therapies has improved the survival of patients with advanced RCC over the past 15 years (since 2006), few cases experienced complete res...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenjin, Pan, Xiuwu, Cui, Xingang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561377/
https://www.ncbi.nlm.nih.gov/pubmed/33117708
http://dx.doi.org/10.3389/fonc.2020.573690

Ejemplares similares